This might suggest that Hs-cTnT could then be used as a biomarker of LMN involvement in ALS and maybe also in other neuromuscular diseases, and could then be used as a screening tool even outside neurological practice, given that it is inexpensive and readily available. The gene discussed is TNNT2; the disease is amyotrophic lateral sclerosis.